PDCD1 and neoplasm: showed that the metabolite butyrate of the gut microbiota, promotes the efficacy of anti-PD-1 therapy by modulating T cell receptor (TCR) signaling of cytotoxic CD8 T cells, and the metabolite butyrate may be a very promising therapeutic biomarker for enhancing anti-tumor immunity (135).Sarkar et al.